Predictors of large volume paracantesis induced circulatory dysfunction in patients with massive hepatic ascites

Journal of Cardiovascular Disease Research

Volumn 1, Issue 3, 2010, Pages 136-144

  Nasr, G ^a   Hassan, A ^a   Ahmed, S ^a   Serwah, A ^a  

^a Suez Canal University Faculty of Medicine   (Egypt)

Author keywords

Circulatory dysfunction; hepatic cardiomyopathy; massive hepatic ascites

Indexed keywords

PLASMA SUBSTITUTE;

ADULT; AGE; AGED; ARTERIAL PRESSURE; ARTICLE; CLINICAL ARTICLE; DIASTOLE; ECHOCARDIOGRAPHY; FEMALE; HEART EJECTION FRACTION; HEART OUTPUT; HEART RATE; HUMAN; INCIDENCE; LARGE VOLUME PARACENTESIS; LIVER CIRRHOSIS; LIVER DISEASE; MALE; MASSIVE HEPATIC ASCITES; PARACENTESIS; PARACENTESIS INDUCED CIRCULATORY DYSFUNCTION; PRIORITY JOURNAL; RISK FACTOR; VASCULAR DISEASE;

EID: 79953033383     PISSN: 09753583     EISSN: 09762833     Source Type: Journal    
DOI: 10.4103/0975-3583.70914     Document Type: Article

References (57)

1. Gines P, Uintero E, Arroyo V. Compensated cirrhosis: Natural history and prognostic factors Hepatology 1987;7:122-8. (Pubitemid 17019862)
2. D'Amico G, Morabito A, Pagliaro L, Marubini E, Caltagirone M, Filippazzo G, et al. Survival and prognostic indicators in compensated and decompensated cirrhosis. Dig Dis Sci 1986;31:468-75.
3. Runyon BA. Management of adult patients with ascites caused by cirrhosis. Hepatology 1998;27;264-72. (Pubitemid 28041563)
4. Bernardi M, Laffi G, Salvagnini M, Azzena G, Bonato S, Marra F, et al. Efficacy and safety of the stepped care medical treatment of ascites in liver cirrhosis: A randomized controlled clinical trial comparing two diets with different sodium content. Liver 1993;13:156-62. (Pubitemid 23228712)
5. Angeli P, Dalla Pria M, De Bei E, Albino G, Caregaro L, Merkel C, et al. A randomized clinical study of the efficacy of amiloride and potassium canrenoate in nonazotemic cirrhotic patients with ascites. Hepatology 1994;19:72-9. (Pubitemid 24020474)
6. Runyon BA. Care of patients with ascites. N Engl J Med 1994;330:337-42. (Pubitemid 24984679)
7. Arroyo V, Gines P, Gerbes AL, Dudley FJ, Gentilini P, Laffi G, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Hepatology 1996;23:164-76. (Pubitemid 26012105)
8. Gines P, Arroyo V, Quintero E. Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites: Results of a randomized study. Gastroenterology 1987;93:234-41. (Pubitemid 17097585)
9. Ferral H, Bjarnason H, Wegryn SA, Rengel GJ, Nazarian GK, Rank JM, et al. Refractory ascites: Early experience in treatment with transjugular intrahepatic portosystemic shunt. Radiology 1993;189:795-801. (Pubitemid 23354498)
10. Salerno F, Badalamenti S, Incerti P. Repeated paracentesis and i.v. albumin infusion to treat ′tense′ ascites in cirrhotic patients: a safe alternative therapy. J Hepatol 1987;5:102-8. (Pubitemid 17119082)
11. Sola R, Vila MC, Andreu M, Oliver MI, Coll S, Gana J, et al. Total paracentesis with dextran 40 vs diuretics in the treatment of ascites in cirrhosis. J Hepatol 1994;20:282-8. (Pubitemid 24086845)
12. Cotrim HP, Garrido V, Parana R, Santana G, Dultra D, Pinto M, et al. Paracentesis associated to dextran-70 in the treatment of ascites in patients with chronic liver diseases. Arq Gastroenterol 1994;31:125-9.
13. Fernandez-Esparrach G, Guevarra M, Sort P, Pardo A, Jimenez W, Gines P, et al. Diuretic requirements after therapeutic paracentesis in non-azotemic patients with cirrhosis. J Hepatol 1997;26:614-20.
14. Ochs A, Rossle M, Haag K, Hauenstein KH, Deibert P, Siegerstetter V, et al. The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites. N Engl J Med 1995;332:1192-7.
15. Shiffman ML, Jeffers L, Hoofnagle JH, Tralka TS. The role of transjugular intrahepatic portosystemic shunt for treatment of portal hypertension and its complications: A conference sponsored by the National Digestive Diseases Advisory Board. Hepatology 1995;22:1591-7.
16. Casado M, Bosch J, Garcia-Pagan JC, Bru C, Banares R, Bandi JC, et al. Clinical events after transjugular intrahepatic portosystemic shunt: Correlation with hemodynamic findings. Gastroenterology 1998;114:1296-303. (Pubitemid 28243916)
17. Gins P, Uriz J, Calahorra B, Garcia-Tsao G, Kamath PS, Del Arbol LR, et al. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis. Gastroenterology 2002;123:1839-47. (Pubitemid 35408308)
18. Arroyo V, Colmenero J. Ascites and hepatorenal syndrome in cirrhosis: Pathophysiological basis of therapy and current management. J Hepatol 2003;38:S69-89.
19. Moore KP, Wong F, Gines P, Bernardi M, Ochs A, Salerno F, et al. The management of ascites in cirrhosis: Report on the consensus conference of The International Ascites Club. Hepatology 2003;38:258-66. (Pubitemid 36775818)
20. Gines P, Tito L, Arroyo V, Planas R, Panes J, Viver J, et al. Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis Gastroenterology 1988;94:1493-502.
21. Ruiz-del-Arbol L, Monescillo A, Jimenez W, Garcia-Plaza A, Arroyo V, Rodes J. Paracentesis-induced circulatory dysfunction: mechanism and effect on hepatic hemodynamics in cirrhosis. Gastroenterology 1997;113:579-86. (Pubitemid 27351786)
22. Vila MC, Sola R, Molina L, Andreu M, Coll S, Gana J, et al. Hemodynamic changes in patients developing effective hypovolemia after total paracentesis. J Hepatol 1998;28:639-45. (Pubitemid 28168002)
23. Boyer TD. The End of the road: Esophageal Varices and Ascites. [Annual AGA 2001 Spring Postgraduate Course, Session IV: Liver, Biliary Tract and Pancreas-Management Issues]. Program and abstracts of Digestive Disease Week 2001; May 19-23, 2001; Atlanta, Georgia.
24. Gines A, Fernandez-Esparrach G, Monescillo A, Vila C, Domenech E, Abecasis R, et al. Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis. Gastroenterology 1996;111:1002-10. (Pubitemid 26327603)
25. Tito L, Gines P, Arroyo V, Planas R, Panes J, Rimola A, et al. Total paracentesis associated with intravenous albumin management of patients with cirrhosis and ascites. Gastroenterology 1990;98:146-51. (Pubitemid 20017796)
26. Runyon BA. Paracentesis of ascitic fluid: A safe procedure. Arch Intern Med 1986;146:2259-61. (Pubitemid 17189105)
27. McVay PA, Toy PT. Lack of increased bleeding after paracentesis and thoracocentesis in patients with mild coagulation abnormalities. Transfusion 1991;13:164-71.
28. Degoricija V, Zjacic-Rotkvic V, Marout J, Sefer S, Troskot B. Clinical and neurohumoral response to posture, physical exercise, and ascites treatment in Child Pugh C liver cirrhosis: Randomized prospective trial. Croat Med J 2003;44:178-86. (Pubitemid 36548078)
29. Gines P, Arroyo V, Quintero E. Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Gastroenterology 1987;93:234-41. (Pubitemid 17097585)
30. Salerno F, Badalamenti S, Incerti P. Repeated paracentesis and i.v. albumin infusion to treat ′tense′ ascites in ascetic patients: A safe alternative therapy. J Hepatol 1987;5:102-8. (Pubitemid 17119082)
31. Pinto PC, Amerian J, Reynolds TB. Large volume paracentesis in non-edematous patients with tense ascites: Its effect on intravascular volume. Hepatology 1988;8:207-10.
32. Sola-Vera J, Such J. Understanding the mechanisms of paracentesis-induced circulatory dysfunction. Eur J Gastroenterol Hepatol 2004;16:295-8. (Pubitemid 38368373)
33. Gines P, Tito L, Arroyo V, Planas R, Panes J, Viver J, et al. Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis. Gastroenterology 1988;94:1493-502.
34. Planas R, Gines P, Arroyo V, Llach J, Panes J, Vargas V, et al. Dextran-70 versus albumin as plasma expanders in cirrhotic patients with tense ascites treated with total paracentesis. Gastroenterology 1990;99:1736-44.
35. Sola-Vera J, Minana J, Ricart E, Planella M, Gonzalez B, Torras X, et al. Randomized trial comparing albumin and saline in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients with ascites. Hepatology 2003;37:1147-53. (Pubitemid 36538692)
36. Llach J, Gines P, Arroyo V, Rimola A, Tito L, Badalamenti S, et al. Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites. Gastroenterology 1988;94:482-7. (Pubitemid 18054789)
37. Mller S, Wiinberg N, Henriksen JH. Noninvasive 24-hour ambulatory arterial blood pressure monitoring in cirrhosis. Hepatology 1995;22:88-95.
38. Mller S, Henriksen JH. Circulatory abnormalities in cirrhosis with focus on neurohumoral aspects. Semin Nephrol 1997;17:505-19. (Pubitemid 27465009)
39. Henriksen JH, Mller S, Ring-Larsen H, Christensen NJ. The sympathetic nervous system in liver disease. J Hepatol 1998;29:328-41. (Pubitemid 28352822)
40. Levy M, Maher E, Wexler MJ. Euvoluemic cirrhotic dogs in sodium balance maintain normal systemic hemodynamics. Can J Physiol Pharmacol 1988;66:80-3. (Pubitemid 18090949)
41. Fernandez-Rodriguez CM, Prieto J, Zozaya JM, Quiroga J, Guitian R. Arteriovenous shunting, hemodynamic changes, and renal sodium retention in liver cirrhosis. Gastroenterology 1993;104:1139-45. (Pubitemid 23090769)
42. Pozzi M, Osculati G, Boari G, Serboli P, Colombo P, Lambrughi C, et al. Time course of circulatory and humoral effects of rapid total paracentesis in cirrhotic patients with tense refractory ascites. Gastroenterology 1994;106:709-19. (Pubitemid 24064339)
43. Wang SS, Chen CC, Chao Y, Wu SL, Lee FY, Lin HC. Sequential hemodynamic changes for large volume paracentesis in post-hepatitic cirrhotic patients with massive ascites. Proc Natl Sci Counc Repub China B 1996;20:117-22.
44. Luca A, Garcia-Pagan JC, Bosch J, Feu F, Jimenez W, Gines A, et al. Beneficial effects of intravenous albumin infusion on the hemodynamic and humoral changes after total paracentesis Hepatology 1995;22:753-8.
45. Coll S, Vila MC, Molina L, Gimenez MD, Guarner C, Sola R. Mechanisms of early decrease in systemic vascular resistance after total paracentesis: Influence of flow rate of ascites extraction. Eur J Gastroenterol Hepatol 2003;15:347-53. (Pubitemid 38368381)
46. Cabrera J, Falcon L, Gorriz E, Pardo MD, Granados R, Quinones A, et al. Abdominal decompression plays a major role in early postparacentesis haemodynamic changes in cirrhotic patients with tense ascites. Gut 2001;48:384-9. (Pubitemid 32269568)
47. Vila MC, Sola R, Molina L, Andreu M, Coll S, Gana J, et al. Hemodynamic changes in patients developing effective hypovolemia after total paracentesis. J Hepatol 1998;28:639-45. (Pubitemid 28168002)
48. Moreau R, Asselah T, Condat B, De Kerguenec C, Pessione F, Bernard B, et al. Comparison of the effect of terlipressin and albumin on arterial blood volume in patients with cirrhosis and tense ascites treated by paracentesis Gut 2002;50:90-4. (Pubitemid 34028309)
49. Singh V, Kumar R, Nain CK, Singh B, Sharma AK. Terlipressin versus albumin in paracentesis induced circulatory dysfunction. J Gastroenterol Hepatol 2006;21:303-7.
50. Singh V, Kumar B, Nain CK, Singh B, Sharma N, Bhalla A, et al. Noradrenaline and albumin in paracentesis-induced circulatory dysfunction in cirrhosis. J Intern Med 2006;260:62-8. (Pubitemid 43894071)
51. Huonker M, Schumacher YO, Ochs A, Sorichter S, Keul J, Rssle M. Cardiac function and haemodynamics in alcoholic cirrhosis and effects of the transjugular intrahepatic portosystemic stent shunt. Gut 1999;44:743-8. (Pubitemid 29195928)
52. Keller H, Bezjak V, Stegaru B, Buss J, Holm E, Heene DL. Ventricular function in cirrhosis and portasystemic shunt: A two-dimensional echocardiographic study. Hepatology 1988;8:658-62.
53. Askanas A, Udoshi M, Sadjadi SA. The heart in chronic alcoholism: A non-invasive study. Am Heart J 1980;99:9-16. (Pubitemid 10203493)
54. Sherif SM, El-Damarawy M, Abdel Daien K, Abo Elsaud M. Evaluation of left ventricular function in nonalcoholic liver cirrhosis. Arab J Gastroenterol 2004;5:37-44.
55. Aziz MY, El Bandart M, Refaie WM. Cardiac Abnormalities in chronic liver disease of different etiologies. Arab J Gastroenterol 2004;5:45-58.
56. Pozzi M, Carugo S, Boari G, Pecci V, De Ceglia S, Maggiolini S, et al. Evidence of functional and structural cardiac abnormalities in cirrhotic patients with and without ascites Hepatology 1997;26:1131-7. (Pubitemid 27509293)
57. Frith J, Jones D, Newton J. Chronic liver disease in an ageing population. Age Ageing 2009;38:11-8.